Hyloris Pharmaceuticals SA (52U) Financial Statements

Compare

7 Followers

Hyloris Pharmaceuticals SA Financial Overview

Hyloris Pharmaceuticals SA's market cap is currently €147.84M. The company's EPS TTM is €; its P/E ratio is -24.62; Hyloris Pharmaceuticals SA is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	€ 10.04M	€ 2.09M	€ 2.95M	€ 3.10M	€ 175.00K
Gross Profit	€ 9.81M	€ 1.99M	€ 2.86M	€ 2.99M	€ 30.00K
Operating Income	€ -7.13M	€ -15.99M	€ -11.64M	€ -4.94M	€ -7.03M
EBITDA	€ -4.85M	€ -14.98M	€ -11.43M	€ -10.78M	€ -6.17M
Net Income	€ -6.34M	€ -15.38M	€ -11.91M	€ -11.58M	€ -7.15M
Balance Sheet
Cash & Short-Term Investments	€ 24.15M	€ 30.41M	€ 43.46M	€ 50.54M	€ 64.41M
Total Assets	€ 41.34M	€ 47.68M	€ 61.86M	€ 63.44M	€ 69.18M
Total Debt	€ 1.81M	€ 1.75M	€ 885.00K	€ 12.29M	€ 8.45M
Net Debt	€ -21.78M	€ -28.66M	€ -42.57M	€ -37.72M	€ -55.95M
Total Liabilities	€ 9.19M	€ 8.61M	€ 6.82M	€ 15.39M	€ 10.12M
Stockholders' Equity	€ 32.14M	€ 39.07M	€ 53.91M	€ 48.06M	€ 59.06M
Cash Flow
Free Cash Flow	€ -6.73M	€ -13.11M	€ -13.89M	€ -12.31M	€ -5.19M
Operating Cash Flow	€ -6.70M	€ -12.81M	€ -13.15M	€ -11.25M	€ -4.57M
Investing Cash Flow	€ 259.00K	€ 9.89M	€ -1.24M	€ -3.08M	€ -633.00K
Financing Cash Flow	€ -368.00K	€ -131.00K	€ 7.84M	€ -62.00K	€ 69.40M

Currency in EUR

Hyloris Pharmaceuticals SA Earnings and Revenue History

Income Statement >

Hyloris Pharmaceuticals SA Debt to Assets

Balance Sheet >

Hyloris Pharmaceuticals SA Cash Flow

Cash Flow >

Hyloris Pharmaceuticals SA Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >